Vetoquinol Universal Registration Document 2019

1 Vetoquinol  Universal Registration Document 2019  Financial report   15 PRESENTATION OF THE GROUP Value-creating business model OUR SHARED VALUE CREATION Customers • Vets/breeders/pet owners • Operational excellence • “Customer-centricity” initiative Shareholders • Sustainable performance • EBITDA > 16% of sales • EBIT > 11% of sales • Continued dividend policy Employees • Skills development (> 68,000h training) • Great Place to Work Environmental • Decarbonized mobility Suppliers and partners • > 1,000 suppliers • > 50 partners Society • Commitments and ethics • Gaia Rating • Sustainable business Essentials products Operational excellence Sourcing Research innovation Digital solutions veterinary industry Top 20 global players > 75% of the market Small series production (liquids, powders, pills, etc.) OUR STRATEGY Focus on 4 species (dogs/cats and cattle/pigs), 3 territories and 6 therapeutic domains